Prescribing pattern of antidiabetic drugs in type 2 diabetic patients of Noakhali city in Bangladesh

Yıl 2017, Cilt: 21 Sayı: 4, 1010 - 1014, 01.12.2017

Anwesha Chowdhury Niloy Sen Sujan Banik

Öz

The aim of the study was to describe the recent trends in the

prescription pattern of antidiabetic drugs and sociodemographic

characteristics of type 2 diabetic patients in Noakhali city of

Bangladesh. This hospital based prospective, cross-sectional

study was carried out in three diabetic hospitals of Noakhali

during the period of December, 2016 to February, 2017. A total

of 200 outpatients were included in this study by following

simple random procedure. Among 200 participants, 73.5%

were treated with monotherapy and 26.5% were treated with

polytherapy with the highest percentage (37.5%) of commonly

prescribed group drugs of sulfonylureas, but lonely metformin

(biguanide) was the most commonest (28%) drug among

oral hypoglycemic agents. The most accounted fixed dose

combination was sulfonylurea with biguanide, and biguanide

with glucodiase inhibitors. The highly prescribed insulin

preparations was insulin mixtures (11%) among the patients.

Drugs were prescribed by traditional brand names (100%) of

different local or foreign companies and 15% of prescription

were contained at least one multivitamin supplement. It was

focused from this study that oral hypoglycemic agents (OHA)

yet dominate the prescribing pattern, but there was a shifting

trend towards insulin preparation in the management of Type

2 diabetes mellitus.

Anahtar Kelimeler

Anti-diabetic drugs; diabetes; oral hypoglycemic agents (OHA); metformin; prescribing pattern.

Kaynakça

• 1. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26:S5- 20. 2. Gerick JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 1998; 19: 491–503. 3. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications, estimates and projections to the year 2010. Diabetes Med 1997; 14: S1-S85. 4. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31. 5. Mazid MA. Thoughts on Diabetic Awareness Day. The Financial Express. 2013. Available at ; http://print. thefinancialexpress-bd.com/old/index.php? (Last access ; 01 July 2017) 6. Davis SN. Goodman and Gilman`s The Pharmacological Basis of Therapeutics, 11th ed. McGraw‑Hill, United States of America. 2006, pp 1613‑1645. 7. Powers AC, Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, editors. Harrison`s Principles of Internal Medicine, 16th ed. McGraw‑Hill, New York. 2005, pp 2152‑2180. 8. Sultana A, Banik S, Hossain MS, Billah MM, Afrin F. The prevalence of childhood overweight and obesity in the children of Noakhali city in Bangladesh. J Res Obes 2016; 2016: Article ID 216173. 9. Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm 2014; 5: 79-83. 10. Hasamnis A, Patil S. Prescription pattern study in type 2 diabetes mellitus in an Indian referral hospital. Internet J Pharmacol 2008; 7: 1. 11. Sutharson L, Hariharan RS, Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Indian J Pharmacol 2003; 35: 237‑40.